| Tag | Content |
|---|
EnhancerAtlas ID | HS089-08706 |
Organism | Homo sapiens |
Tissue/cell | Hela |
Coordinate | chr22:40651540-40652360 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxd3 | MA0041.1 | chr22:40651849-40651861 | GTTTGTTTGTTT | + | 6.32 | | Foxd3 | MA0041.1 | chr22:40651853-40651865 | GTTTGTTTGTTT | + | 6.32 | | Foxd3 | MA0041.1 | chr22:40651857-40651869 | GTTTGTTTGTTT | + | 6.32 | | Foxd3 | MA0041.1 | chr22:40651861-40651873 | GTTTGTTTGTTT | + | 6.32 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_18406 | chr22:40650768-40652070 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_18406 | chr22:40652244-40653448 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH22I040254 | chr22 | 40650769 | 40652070 | | GH22I040256 | chr22 | 40652245 | 40653448 |
|
Enhancer Sequence | TGGGGAGCCA CTTGTTCAGA GGTGGAACTG GCTGCCCCTA AGAGAGTGAA TGAACGTGAG 60
GTATTACAAG ACATGTGGCT CCAATAAATT GGCATGAAAA TAGTCCAAAT AGGAGGTAAT 120
GAGGACTTGA ACCCGATTAG GAGGCCAGGT GTTTAAACCT TCCTGAGTTG ACAAATTCCT 180
TGCCCAATCT GGCCCGAACT ACACAAGGTC CATGGAGGTT GCTCTCTGTT CCTTTTCACA 240
GTGTGGTGCA GGAAGTGTAA ATCCCTTCCT GGATACTGTA TGTCTATTAA TGCAGGTGTT 300
TGTTTGCTTG TTTGTTTGTT TGTTTGTTTG TTTTGAGACA GAGTCTTGCT CTGTTGCCCC 360
AGCTGGAGTG CAATGGCATG ATCTTGGCTC ACTGCAACCT CCGCCTCCCA GGTTCAAGCG 420
ATTCTCCTGC CTCAGCCTCC TGAGTAGTTG GGACTACAGG CACATGCCAC CACGCCTGGC 480
TAATTTTTTG TATTTTTAGT AGAGACGGGG TTTCACTGTG TTAGCCAGGA ATTGAGAGAG 540
GCTTTAGTTT AACTTAATAT TGATTGGATA ATGATATGTG GGTGGGGGAA CATTGAGAAG 600
TCTAAGATAC CAAGCAGGTT TCTGACTTGA GCAGCTGGTT CGGTGATAAG TTCATTCTTT 660
GAGGGTGAAG AAATGAGATT GGGGCTAGGA AACAAGTTTG AGAGGAAGGG AAAGATGATA 720
AGTGGTAGTT AAAGCCAGAG CATGGAAGAG TTTGTACTCA AGGAACTGAA ATGTGGAAAG 780
GGTGCAGACC CTATTGTCAC ATTGATTTTG TTTTGTTTTG 820
|
